Rheumatoid arthritis, cytokines and hypoxia. What is the link?

Saudi Medical Journal

Volumn 27, Issue 11, 2006, Pages 1642-1649

  Al Shukaili, Ahmed K ^a   Al Jabri, Ali A ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA CHEMOKINE; BUTHIONINE SULFOXIMINE; CD4 ANTIGEN; CD45RO ANTIGEN; CYCLOOXYGENASE 2; CYTOKINE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 11; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; CELL HYPOXIA; CELL POLARITY; CYTOKINE PRODUCTION; GROUPS BY AGE; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PROTEIN SYNTHESIS INHIBITION; REVIEW; RHEUMATOID ARTHRITIS; SEX RATIO; SYNOVITIS; T LYMPHOCYTE; UPREGULATION; ADULT; AGE; AGED; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; IMMUNOLOGY; JOINT; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEX DIFFERENCE; SYNOVIUM;

ADULT; AGE FACTORS; AGED; ARTHRITIS, RHEUMATOID; CELL HYPOXIA; CYTOKINES; DISEASE PROGRESSION; FEMALE; HUMANS; JOINTS; MACROPHAGES; MALE; MIDDLE AGED; OXIDATIVE STRESS; SEX FACTORS; SYNOVIAL MEMBRANE; T-LYMPHOCYTES;

EID: 34250830437     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Sewell KL, Trentham DE. Pathogenesis of rheumatoid arthritis. Lancet 1993; 34: 283-286.
2. Snowden N, Kay RA. Immunology of systemic rheumatoid disease. Br Med Bull 1995; 51: 437-448.
3. Venables PJ. Infection and rheumatoid arthritis. Curr Opin Rheumatol 1989; 1: 15-20.
4. Hyrich KL, Inman RD. Infectious agents in chronic rheumatic diseases. Curr Opin Rheumatol 2001; 13: 300-304.
5. Tarkowaski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ. Secretion of antibodies to type-I and II collagen by synovia1 tissue-cells in patient with rheumatoid arthritis. Arthritis Rheum 1989; 32: 1087-1092.
6. Winchester R, Gregersen PK, Merryman P, Dwyer E, Lee S. Hypotheses on the molecular basis of susceptibility to rheumatoid arthritis. Scand J Rheumatol Suppl 1988; 76: 9-16.
7. Choi YW, Herman A, Digiusto D, Wade T, Marrack P. Kappler J. Residues of the variable region of the T cell-receptor beta-chain that interact with staphylococcus-aureus toxin superantigens. Nature 1990; 346: 471-473.
8. Lohmander LS, Hoerrner LA, Dahlberg L, Roos H, Bjornsson S, Lark MW. Stromelysin, tissue inhibitor of Metalloproteinase and proteoglycan fragments in human knee-joint fluid after injury. J Rheumatol 1993; 20: 1362-1368.
9. Boots AMH, Verheijden GFM, Schoningh R, van Staveren CJ, Bos Ebo, Elewaut D, et al. Selection of self-reactive peptides within human aggrecan by use of HLA-DRB 1*0401 peptide binding motif. J Autoimmun 1997; 10: 569-578.
10. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in balb/c mice-clinical-features and histopathology. Arthritis Rheum 1987; 30: 201-212.
11. Baeten D, Boots AM, Steenbakkers PG, Elewaut D, Bos ES, Verheijden GF, et al. Human cartilage gp-39+, CD 16+ monocytes in peripheral blood and synovium: Correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 2000; 43: 1233-1243.
12. Corrigall VM, Panayi GS. Autoantigens and immune pathways in rheumatoid arthritis. Crit Rev Immunol 2002; 22: 281-293.
13. Scott DL. Prognostic factors in early rheumatoid arthritis. Rheumatol 2000; 39: 24-29.
14. Singeal DP, Li J, Lei K. Genetics of rheumatoid arthritis (RA): Two separate regions in the major histocompatibility complex contribute to susceptibility to RA. Immunol Lett 1999; 69: 301-306.
15. Smith JB, Haynes MK. Rheumatoid arthritis-A molecular understanding. Ann Intern Med 2002; 136: 908-922.
16. Panayi GS. Targeting of cells involved in the pathogenesis of rheumatoid arthritis. Rheum 1999; 38: 8-10.
17. Manicourt DH, Fujimoto N, Ken'ichi O, Thonar EJ-M. Levels of circulating collagenase stromelysin-I, and tissue inhibitor of matrix metalloproteinase I in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 1031-1039.
18. Vincenti MP, Brinckerhoff CF. Transcriptional regulation of collagenase (MMP-1, MMP-8 and MMP13) gene in arthritis. Arthitis Res 2002; 4: 157-164.
19. Nemoto O, Yamada H, Mukaida M, Shimmnei M. Stimulation of TIMP-1 production by oncostatin M in human cartilage. Arthitis Rheum 1996; 39: 560-566.
20. Vincenti MP, Coon CI, Lee O, Brinckerhoff CF. Regulation of collagenase gene expression by IL-1-beta requires transcriptional and posttranscriptional mechanisms. Nuc Acids Res 1994; 22: 4818-4827.
21. Feldmann M, Brennan FM, Maini N. The role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996; 14: 397-440.
22. Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis-mastermind or workhorse in arthritis? Arthritis Rheum 1997; 40: 5-18.
23. Dayer JM, Fenner H. The role of cytokine and their inhibitors in arthritis. Baillier's Clin Rheumatol 1992; 6: 486-516.
24. Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A. Gal A, et al. Cytokine production by synovial cells in rheumatoid arthritis. Rheumatol 1999; 38: 202-213.
25. Arend WP, Dayer IM. Inhibition of the production and effects of Interleukin-I and tumour necrosis factor-α in rheumatoid arthritis. Arthritis Rheum 1995; 38: 151-160.
26. Loetscher H, Gentz R, Zulauf M. Lustig A. Tabochi H, Schlaeger, et al. Recombinant 55-kDa tumor-necrosis factor (TNF) receptor stoichiometry of binding to TNF alpha and TNF-beta and inhibition of TNF activity. J Bio Chem 1991; 266: 18324-18329.
27. Dinarello CA. Biological basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147.
28. Arend WP. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: The role of interleukin-1 receptor antagonist. Semin Arrhtitis Rheum 2001; 30: 1-6.
29. Arend WP. Cytokines and cellular interactions in inflammatory synovitis. J Clin Invest 2001; 107: 1081-1082.
30. Hsu HC, Wu Y, Mountz JD. Tumor necrosis factor ligand-receptor superfamily and arthritis. Curr Dis Autoimmunity 2006; 9: 37-54.
31. Maini R, Breedveld F, Kalden J, Smolen J, Davis D, Macfarlane J, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor-α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid. arthritis. Arthritis Rheum 1998; 41: 1552-1563.
32. Breedveld FC. Future trends in the treatment of rheumatoid arthritis: cytokine targets. Rheumatol 1999; 38: 11-13.
33. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunol Today 1997; 18: 428-432.
34. Sakkas L, Johanson N, Scanzello C, Platsoucas C. Interleukin-12 is expressed by infiltrating macrophages and syntovial lining cells in rheumatoid arthritis and osteoarthritis. Cellu Immunol 1998; 188: 105-110.
35. Fehniger TA, Caligiuri MA. Interleukin-15: Biology and relevance to human diseases. Blood 2001; 97: 14-32.
36. Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models. Arthritis Res Ther 2005; 7: 29-37.
37. McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew F. Interleukin-18: pleiotropic participant in chronic inflammation. Immunol Today 2000; 21: 312-315.
38. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Zumbuschenfelde KHM, Neurath MF. Cutting Egde: IL-12 and IL-18 differentially regulate the transcriptional activity of the human interferon-gamma promoter in primary CD4+ T lymphocytes. J Immunol 1998; 160: 3642-3647.
39. Plater-Zyberk C, Joonsten L, Helsen M, Sattonnet-Roche P, Siegfried C, Alouani S, et al. CD14 is pattern recognition receptors. Immunity 1994; 1: 509-516.
40. Lochner M, Wagner H, Classen M, Forster I. Generation of neutralizing mouse anti-mouse IL-18 antibodies for inhibition of inflammatory responses in vivo. J Immunol Meth 2002; 259: 149-157.
41. De Benedetti F, Pignatti P, Massa M, Sartirana P, Ravelli A, Martini A. Circulating levels of interleukin-1 beta and of interleukin-1 receptor antagonist in systemic juvenile chronic arthritis. Clin Exp Rheumatol 1995; 13: 779-784.
42. Chikanza IC, Kingsley G, Panayi GS. Peripheral-blood and synovial fluid monocytes expression of interleukin-1 alpha and beta during active rheumatoid arthritis. J Rheumatol 1995; 22: 600-606.
43. Gabay C, Gaycroisier F, Rouxlombard P, Meyer O, Maineti C, Guene PA, et al. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis-a biologic market of disease-activity with a possible role in the lack of acute-phases protein response. Arthiritis Rheum 1994; 37: 1744-1751.
44. Suzuki H, Takemura H, and Kashiwagi H. IL-1 receptor antagonist (IL-1 ra) in patients with systemic lupus erythematosus (SLE). FASEB J 1995; 9: A1029.
45. Arend W, Smith M, Janson R, Joslin F. IL-1 receptor antagonist and IL-1α production in human monocytes are regulated differently. J Immunol 1991; 147: 1530-1536.
46. Firestein G, Boyle D, Yu C, Paine M, Whisenand T, Zvaifler N, et al. Synovial interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994; 37: 644-652.
47. Cunnane G, Madigan A, Murphy E, FitzGerald O, Bresniham B. The effect of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis. Rheum 2001; 40: 62-69.
48. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-α Ann Rev Immunol 1998; 16: 137-161.
49. Collotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, et al. Interleukin-1 type-II receptor a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472-475.
50. Abramson V, Gallin JI. IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 1994; 144: 625-630.
51. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-1527.
52. Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor and oncostatin M in rheumatoid arthritis. Arthritis Rheum 1997; 40: 1096-1105.
53. Hermann J, Hall MA, Maini R, Feldmann M, Brennan FM. Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1388-1397.
54. Mapp PI, Grootveld, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 1995; 51: 419-436.
55. Bodamyali T, Stevens CR, Billingham MEJ, Ohta S, Blake DR. Influence of hypoxia in inflammatory synovitis. Ann Rheum Dis 1998; 57: 703-710.
56. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT. Role of oxidants in NF-αβ activation and TNF-α gene transcription induced by hypoxia and endotoxin. J Immunol 2000; 165: 1013-1021.
57. Chandhri G, Hunt NH, Clark IA, Cereding R. Antioxidants inhibit proliferation and cell-surface expression of receptors for interleukin-2 and transferring in lymphocytes-1 stimulated with phorbol-myristate acetate and ionomycin. Cell Immunol 1988; 115: 204-213.
58. Ghezzi P, Dinarello CA, Bianchi M, Rosandich M, Repine J, White C. Hypoxia increases production of interleukin-1 and tumour necrosis factor by human mononuclear cells. Cytokine 1991; 3: 189-194.
59. Kono K, SalazarOnfray F, Petersson M, Hansson J, Masucci G, Wasserman K, et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell and natural killer cell-mediated cytotoxicity. Eur J Immunol 1996; 26: 1308-1313.
60. Anderson ME. Glutathione: An overview of biosynthesis and modulation. Chemico-Biological Interactions 1998; 111-112: 1-14.
61. Haddad JJ. The involvement of L-α-glutamyl-1-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPKp38-dependent regulation of pro-inflammatory cytokine production. Biochem Pharmacol 2002; 63: 305-320.
62. Hashimoto S, Gon Y, Matsumoto K, Takeshita I, and Horie T. N-acetylcysteine attenuates TNF-α-induced p38 MAPkinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br J Pharmacol 2001; 132: 270-276.
63. Utsugi M, Dobashi K, Koga Y, Shimizu Y, Iizuka K, Hamura J, et al. Glutathione redox regulates lipopolysaccharide-induced IL-12 production through p38 mitogen-activated protein kinase activation in human monocytes: Role of glutathione redox in IFN-gamma priming of IL-12 production. J Leukoc Biol 2002; 71: 339-347.
64. Hashimoto S, Gon Y, Matsumoto K, Takeshita I, Machino T, Horie T. Intracellular glutathione regulates tumour necrosis factor-α induced p38 MAP kinase activation and RANTES production. Clin Exp Allergy 2001; 31: 144-151.
65. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003; 60: 6-20.
66. Viora M, Quaranna M, Straface E, Vari R, Masella R, Malorni W. Redox imbalance and immune functions: Opposite effect of oxidized low-density lipoproteins and N-acetylcysteine. Immunol 2001; 104: 431-438.
67. Dobashi K, Aihara M, Araki T, Shimizu Y, Utsugi M, Iizuka K, et al. Regulation of LPS induced IL-12 production by IFN-α and IL-4 through intracellular glutathione status in human macrophages. Clin Exp Immunol 2001; 124: 290-296.
68. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT. Role of oxidants in NF-αβ activation and TNF-α gene transcription induced by hypoxia and endotoxin. J Immunol 2000; 165: 1013-102.
69. Maurice MM, Nakamura H, Vander Voort EAM, Van Vliet Al, Staal FJT, Tak PP, et al. Evidence for the role of an altered redox state in hyporesponsive of T cells in rheumatoid arthritis. J Immunol 1997; 158: 1458-1465.
70. Gringhuis SI, Leow A, Papendrecht-Van der Voot, Remans PHJ, Breedveld FC, Verweij CL. Displacement of Linker for activation of cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T cells in rheumatoid arthritis. J Immunol 2000; 164: 2170-2179.
71. Gringhuis SI, Ellen AM, Papendrecht-Van der Voot, Leow A, Nivine Levarht EW, Ferdinand C, et al. Effect of redox alteration on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol Cell Biol 2002; 22: 400-411.
72. Murata Y, Shimamura T, Hamura J. The polarization of Th1/Th2 balance is dependent on intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 2002; 14: 201-212.
73. Monick MM, Samavati L, Butter N, Mohning M, Powers L, Yarovinsky T, et al. Intracellular Thiols contribute to Th2 function via positive role in IL-4 production. J Immunol 2003; 171: 5107-5115.